BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 26558034)

  • 1. Metabolic syndrome, obesity and kidney stones.
    Hess B
    Arab J Urol; 2012 Sep; 10(3):258-64. PubMed ID: 26558034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and biochemical profile of patients with "pure" uric acid nephrolithiasis compared with "pure" calcium oxalate stone formers.
    Negri AL; Spivacow R; Del Valle E; Pinduli I; Marino A; Fradinger E; Zanchetta JR
    Urol Res; 2007 Oct; 35(5):247-51. PubMed ID: 17786420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obesity and kidney stone disease: a systematic review.
    Carbone A; Al Salhi Y; Tasca A; Palleschi G; Fuschi A; De Nunzio C; Bozzini G; Mazzaferro S; Pastore AL
    Minerva Urol Nefrol; 2018 Aug; 70(4):393-400. PubMed ID: 29856171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
    Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of being overweight on urinary metabolic risk factors for kidney stone formation.
    Shavit L; Ferraro PM; Johri N; Robertson W; Walsh SB; Moochhala S; Unwin R
    Nephrol Dial Transplant; 2015 Apr; 30(4):607-13. PubMed ID: 25362001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of metabolic syndrome traits and severity of kidney stones: results from a nationwide survey on urolithiasis in Japan.
    Kohjimoto Y; Sasaki Y; Iguchi M; Matsumura N; Inagaki T; Hara I
    Am J Kidney Dis; 2013 Jun; 61(6):923-9. PubMed ID: 23433467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of nephrolithiasis, hyperoxaluria, and calcium oxalate supersaturation increased after Roux-en-Y gastric bypass surgery: a systematic review and meta-analysis.
    Upala S; Jaruvongvanich V; Sanguankeo A
    Surg Obes Relat Dis; 2016; 12(8):1513-1521. PubMed ID: 27396545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kidney Stones After Bariatric Surgery: Risk Assessment and Mitigation.
    Espino-Grosso PM; Canales BK
    Bariatr Surg Pract Patient Care; 2017 Mar; 12(1):3-9. PubMed ID: 28465866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roux-en-Y gastric bypass is associated with early increased risk factors for development of calcium oxalate nephrolithiasis.
    Duffey BG; Pedro RN; Makhlouf A; Kriedberg C; Stessman M; Hinck B; Ikramuddin S; Kellogg T; Slusarek B; Monga M
    J Am Coll Surg; 2008 Jun; 206(6):1145-53. PubMed ID: 18501812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium oxalate supersaturation increases early after Roux-en-Y gastric bypass.
    Agrawal V; Liu XJ; Campfield T; Romanelli J; Enrique Silva J; Braden GL
    Surg Obes Relat Dis; 2014; 10(1):88-94. PubMed ID: 23953730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obesity and urolithiasis: evidence of regional influences.
    Trinchieri A; Croppi E; Montanari E
    Urolithiasis; 2017 Jun; 45(3):271-278. PubMed ID: 27488444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypocitraturia and hyperoxaluria after Roux-en-Y gastric bypass surgery.
    Maalouf NM; Tondapu P; Guth ES; Livingston EH; Sakhaee K
    J Urol; 2010 Mar; 183(3):1026-30. PubMed ID: 20096421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperoxaluric nephrolithiasis is a complication of Roux-en-Y gastric bypass surgery.
    Sinha MK; Collazo-Clavell ML; Rule A; Milliner DS; Nelson W; Sarr MG; Kumar R; Lieske JC
    Kidney Int; 2007 Jul; 72(1):100-7. PubMed ID: 17377509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of BMI in nephrolithiasis in an Appalachian pediatric population: A single-center experience.
    Murphy MO; Erpelding SG; Chishti AS; Dugan A; Ziada A; Kiessling SG
    J Pediatr Urol; 2018 Aug; 14(4):330.e1-330.e8. PubMed ID: 29887297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stone formation and management after bariatric surgery.
    Tarplin S; Ganesan V; Monga M
    Nat Rev Urol; 2015 May; 12(5):263-70. PubMed ID: 25850790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age, Body Mass Index, and Gender Predict 24-Hour Urine Parameters in Recurrent Idiopathic Calcium Oxalate Stone Formers.
    Otto BJ; Bozorgmehri S; Kuo J; Canales M; Bird VG; Canales B
    J Endourol; 2017 Dec; 31(12):1335-1341. PubMed ID: 29084490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective evaluation of urinary metabolic indices in severely obese adolescents after weight loss surgery.
    DeFoor WR; Asplin JR; Kollar L; Jackson E; Jenkins T; Schulte M; Inge T
    Surg Obes Relat Dis; 2016 Feb; 12(2):363-7. PubMed ID: 26077697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic syndrome and urinary stone composition: what factors matter most?
    Kadlec AO; Greco K; Fridirici ZC; Hart ST; Vellos T; Turk TM
    Urology; 2012 Oct; 80(4):805-10. PubMed ID: 22795374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal stone disease and obesity: what is important for urologists and nephrologists?
    Ahmed MH; Ahmed HT; Khalil AA
    Ren Fail; 2012; 34(10):1348-54. PubMed ID: 23013150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pathophysiology, diagnosis and conservative therapy in calcium kidney calculi].
    Hess B
    Ther Umsch; 2003 Feb; 60(2):79-87. PubMed ID: 12649986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.